4,900.00
0.00
(0.00%)
As of November 15 at 12:29:55 PM CST. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 22 | 9 | 29 | 29 |
| Avg. Estimate | 580.62M | 551.27M | 2.24B | 2.68B |
| Low Estimate | 524.4M | 500.4M | 2.07B | 2.28B |
| High Estimate | 673.68M | 597.7M | 2.33B | 3.47B |
| Year Ago Sales | 439.72M | 494.33M | 1.83B | 2.24B |
| Sales Growth (year/est) | 32.04% | 11.52% | 22.27% | 19.73% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ALNY.MX | -- | -- | -- | -- |
| S&P 500 | 9.01% | 10.57% | 14.00% | 13.70% |
Upgrades & Downgrades
| Reiterates | RBC Capital: Outperform to Outperform | 1/21/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/13/2025 |
| Reiterates | Needham: Buy to Buy | 1/13/2025 |
| Maintains | Bernstein: Outperform to Outperform | 1/7/2025 |
| Reiterates | Piper Sandler: Overweight to Overweight | 11/18/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/18/2024 |